447 related articles for article (PubMed ID: 24471320)
1. [Pharmacovigilance of parenterally administered salvianolate based on analysis of spontaneous reporting system data].
Lu PF; Xiang YY; Xie YM; Chang YP; Wang ZG
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3003-7. PubMed ID: 24471320
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
Yang W; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
[TBL] [Abstract][Full Text] [Related]
3. [Study of analysis 1 390 adverse drug reactions cases of parenterally administered dengzhan xixin based on China's spontaneous response system].
Li YY; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2998-3002. PubMed ID: 24471319
[TBL] [Abstract][Full Text] [Related]
4. [Spontaneous reporting system data analysis of parenterally administered Shenmai].
Wang LX; Xiang YY; Xie YM; Shen H; Ai QH
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2987-93. PubMed ID: 24471317
[TBL] [Abstract][Full Text] [Related]
5. [Research on early warning signals of adverse drug reactions to parenterally administered xiyanping based on spontaneous reporting system (SRS) data].
Wang ZF; Xiang YY; Xie YM
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3008-12. PubMed ID: 24471321
[TBL] [Abstract][Full Text] [Related]
6. [Spontaneous reportintg system data based on shuxuetong injection adverse reactions signal warning analysis].
Jiang JJ; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2994-7. PubMed ID: 24471318
[TBL] [Abstract][Full Text] [Related]
7. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
8. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal.
Miguel A; Bernardo Marques ; Freitas A; Lopes F; Azevedo L; Pereira AC
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):907-13. PubMed ID: 23761351
[TBL] [Abstract][Full Text] [Related]
9. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
[TBL] [Abstract][Full Text] [Related]
10. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
[TBL] [Abstract][Full Text] [Related]
11. Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria.
Awodele O; Aliu R; Ali I; Oni Y; Adeyeye CM
Pharmacol Res Perspect; 2018 Oct; 6(5):e00427. PubMed ID: 30324768
[TBL] [Abstract][Full Text] [Related]
12. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
Jose J; Rao PG
Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of adverse drug reaction/adverse event and early warning signal mining of Ginkgo biloba Dropping Pills based on SRS data].
Zhang C; Liu H; Xie YM; Wang Q
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2322-2328. PubMed ID: 32495588
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system.
Chen CJ; Cheng CF; Lin HY; Hung SP; Chen WC; Lin MS
J Clin Pharm Ther; 2012 Dec; 37(6):647-51. PubMed ID: 22646235
[TBL] [Abstract][Full Text] [Related]
15. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
Svendsen K; Wood M; Olsson E; Nordeng H
Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
[TBL] [Abstract][Full Text] [Related]
16. Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug's safety profile.
Motola D; Melis M; Lo Bianco S; Buccellato E; Biagi C; Vaccheri A
Expert Opin Drug Saf; 2014 Jul; 13(7):867-73. PubMed ID: 24809453
[TBL] [Abstract][Full Text] [Related]
17. [Adverse drug reactions and prescription errors: morbi-mortality].
Chaio S; Toibaro J; Valicenti P; Saidón P
Medicina (B Aires); 2013; 73(2):111-8. PubMed ID: 23570758
[TBL] [Abstract][Full Text] [Related]
18. Signal detection for Thai traditional medicine: examination of national pharmacovigilance data using reporting odds ratio and reported population attributable risk.
Wechwithan S; Suwankesawong W; Sornsrivichai V; McNeil EB; Jiraphongsa C; Chongsuvivatwong V
Regul Toxicol Pharmacol; 2014 Oct; 70(1):407-12. PubMed ID: 24945744
[TBL] [Abstract][Full Text] [Related]
19. Patterns of adverse drug reaction signals in NAFDAC Pharmacovigilance activities from September to November, 2014.
Awodele O; Ibrahim A; Orhii P
Int J Risk Saf Med; 2016 Mar; 28(1):13-23. PubMed ID: 27176753
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase.
Cliff-Eribo KO; Choonara I; Dodoo A; Darko DM; Sammons H
Expert Opin Drug Saf; 2015; 14(12):1827-33. PubMed ID: 26436964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
